Pamela D. Garzone's most recent trade in Cue Biopharma Inc was a trade of 21,800 Common Stock done . Disclosure was reported to the exchange on July 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Pamela D. Garzone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 21,800 | 21,800 (0%) | 0% | 0 | Common Stock | |
| Cue Biopharma Inc | Pamela D. Garzone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 24,400 | 24,400 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Pamela D. Garzone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 24,400 | 24,400 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | D. Garzone Pamela | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 24,400 | 24,400 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Pamela D. Garzone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) |